Health
Alzheimer’s Breakthrough: Popular Diabetes Drug Ozempic Linked to Much Lower Risk - SciTechDaily
Semaglutide may reduce Alzheimer's risk in type 2 diabetes patients, with research suggesting significant protective benefits compared to other diabetes drugs. Researchers at Case Western Reserve School of Medicine have found that semaglutide, a popu
By: SciTechDaily
- Oct 28 2024
- 0
- 0 Views
Researchers have discovered that semaglutide, a diabetes and weight-loss medication sold under the brand names Wegovy and Ozempic, might significantly reduce the risk of Alzheimer’s in type 2 diabete… [+3673 chars]